This inventor holds 2 USPTO granted patents. Top assignees: American Cyanamid Company, Whitehead Institute for Biomedical Research. Active years: 1992-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,580 
1 out of 318 
Years Active: 1992-1999
Title: Patricia Anne Reilly: Innovator in Viral Vaccine Development
Introduction
Patricia Anne Reilly is a distinguished inventor based in Glen Rock, NJ (US). She has made significant contributions to the field of biomedical research, particularly in the development of viral vaccines. With a total of 2 patents, her work has the potential to impact public health positively.
Latest Patents
Reilly's latest patents include groundbreaking inventions such as replication-competent recombinant viral vaccines and methods for producing replication-competent recombinant viruses. These viruses are designed to include exogenous nucleic acid sequences that encode an exogenous polypeptide, along with a nucleic acid sequence that encodes an artificial proteolytic cleavage site. This innovation allows for the cleavage of the precursor protein produced by the parent virus, resulting in the release of the exogenous polypeptide. The recombinant viruses developed through this method are useful as vaccines against various infections, including bacterial, viral, fungal, and yeast infections, as well as parasitic diseases, cancer, and allergies. Another notable patent involves the gene encoding a 30 kilodalton outer membrane protein of Bordetella pertussis, which relates to a nucleotide and amino acid sequence that can be utilized in vaccine compositions.
Career Highlights
Throughout her career, Patricia has worked with reputable organizations, including the American Cyanamid Company and the Whitehead Institute for Biomedical Research. Her experience in these institutions has allowed her to refine her expertise in vaccine development and biotechnology.
Collaborations
Reilly has collaborated with notable professionals in her field, including Mark B Feinberg and Raul Andino. These partnerships have contributed to her innovative research and the advancement of her patented technologies.
Conclusion
Patricia Anne Reilly's contributions to the field of viral vaccine development are noteworthy. Her innovative patents and collaborations highlight her commitment to improving public health through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile